Delivery Order SPE2DB22D3501-SPE2DB25FXF77
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,727.62 to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities. The contract was competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,840.04 to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of July 30, 2025. The contract carries no set-aside designation, meaning it was competed among all eligible vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities, valued at $6,768.50. This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,294.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% solution (60ml). This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,135.24 firm fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Calcipotriene 0.005% Solution 60ML, a medication, with a ceiling value of $1,524.40 and a performance period ending on May 19, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,487.84 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution, a topical medication. The contract has an ultimate completion date of April 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The $2,757.00 firm fixed price delivery order is for the pharmaceutical product Calcipotriene 0.005% Solution 60ML. Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This award is part of an...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.40, is for the delivery of Calcipotriene 0.005% Solution, a prescription medication. The contract has a completion date of April 7, 2025 and is a Firm Fixed Price contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,956.86 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Cream, a specialty pharmaceutical product, with a performance period through November 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF77Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,069.16 to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by September 10, 2025. The order was placed on September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government healthcare programs. The company's extensive portfolio of federal contract awards demonstrates its capability to meet DLA requirements across multiple therapeutic domains, positioning it as a key vendor within the Defense Logistics Agency's medical supply chain for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/9/25 |